Glide Pharma appoints Dr Ian Smith as its new chief executive

pharmafile | January 12, 2012 | Appointment | Business Services, Manufacturing and Production, Sales and Marketing  

Glide Pharma, a firm focused on the needle-free administration of solid dose therapeutics and vaccines, has appointed Dr Ian Smith to as its new chief executive.

Dr Smith has nearly 30 years’ experience in the drug delivery industry. Previously, he has led the inhalation and device product development groups at both Glaxo and Pfizer. 

He was also head of medical device development at PA Consulting and R&D director at Andaris.

In 2001, he founded drug delivery company Meridica and led the organisation as its chief executive until 2004, when Pfizer acquired it.

Advertisement

Most recently, Dr Smith was director of H12 Consulting, which provides strategic advice to industry and investors on drug delivery technologies.

 

Related Content

No items found
The Gateway to Local Adoption Series

Latest content